Alumnus
Related Expertise: Biopharma, Marketing and Sales, Health Care Industry
By Troy Andre, Ken Keen, Ethan Dabbs, and Stephen Waddell
Being an executive charged with overseeing the commercial activities of a pharmaceutical business has never been tougher. Competition within drug classes is relentless, and getting even a few minutes of face time with doctors is increasingly difficult, if not almost impossible. Regulators and payers continue to flex their muscles, showing favor to generic drugs or their most preferred brands. And R&D labs are failing to produce a steady stream of next-generation products to replace those reaching the end of their patent life. Add to this mix the risk of further health-care reform, and the pharmaceutical commercial market is likely to grow only more challenging.
The authors would like to offer their thanks to Dirk Calcoen, Goetz Gerecke, Simon Goodall, Zhenya Lindgardt, Mark Lubkeman, Juergen Luecke, Peter Tollman, Bernd Ziegler, and other BCG colleagues for contributing their insights on the pharmaceutical commercial market.
Alumnus
ABOUT BOSTON CONSULTING GROUP
Boston Consulting Group partners with leaders in business and society to tackle their most important challenges and capture their greatest opportunities. BCG was the pioneer in business strategy when it was founded in 1963. Today, we work closely with clients to embrace a transformational approach aimed at benefiting all stakeholders—empowering organizations to grow, build sustainable competitive advantage, and drive positive societal impact.
Our diverse, global teams bring deep industry and functional expertise and a range of perspectives that question the status quo and spark change. BCG delivers solutions through leading-edge management consulting, technology and design, and corporate and digital ventures. We work in a uniquely collaborative model across the firm and throughout all levels of the client organization, fueled by the goal of helping our clients thrive and enabling them to make the world a better place.
© Boston Consulting Group 2024. All rights reserved.
For information or permission to reprint, please contact BCG at permissions@bcg.com. To find the latest BCG content and register to receive e-alerts on this topic or others, please visit bcg.com. Follow Boston Consulting Group on Facebook and X (formerly Twitter).